<?xml version="1.0" encoding="UTF-8"?>
<ref id="BST-47-1757C96">
 <label>96</label>
 <mixed-citation publication-type="journal">
  <person-group person-group-type="author">
   <name name-style="western">
    <surname>Rozanov</surname>
    <given-names>D.</given-names>
   </name>, 
   <name name-style="western">
    <surname>Cheltsov</surname>
    <given-names>A.</given-names>
   </name>, 
   <name name-style="western">
    <surname>Nilsen</surname>
    <given-names>A.</given-names>
   </name>, 
   <name name-style="western">
    <surname>Boniface</surname>
    <given-names>C.</given-names>
   </name>, 
   <name name-style="western">
    <surname>Forquer</surname>
    <given-names>I.</given-names>
   </name>, 
   <name name-style="western">
    <surname>Korkola</surname>
    <given-names>J.</given-names>
   </name>
   <etal>et al.</etal>
  </person-group> (
  <year>2019</year>) 
  <article-title>Targeting mitochondria in cancer therapy could provide a basis for the selective anti-cancer activity</article-title>. 
  <source>PLoS ONE</source>
  <volume>14</volume>, 
  <fpage>e0205623</fpage>
  <pub-id pub-id-type="doi">10.1371/journal.pone.0205623</pub-id>
  <pub-id pub-id-type="pmid">30908483</pub-id>
 </mixed-citation>
</ref>
